Of the selected target genes, AMACR and TRIO in 5p and CDK4, HMGA2 and MDM2 in 12q showed significantly (p < 0.05) elevated expression in relation to myxoid liposarcomas (Fig. 5). This evidence concerns the gene HMGA2 and myxoid liposarcoma.